Structure

Physi-Chem Properties

Molecular Weight:  153.08
Volume:  159.036
LogP:  0.291
LogD:  0.604
LogS:  -0.398
# Rotatable Bonds:  1
TPSA:  53.35
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  1
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.63
Synthetic Accessibility Score:  2.523
Fsp3:  0.375
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.52
MDCK Permeability:  1.0096944606630132e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.012
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.318
30% Bioavailability (F30%):  0.083

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.445
Plasma Protein Binding (PPB):  39.8874397277832%
Volume Distribution (VD):  1.178
Pgp-substrate:  58.44963836669922%

ADMET: Metabolism

CYP1A2-inhibitor:  0.211
CYP1A2-substrate:  0.769
CYP2C19-inhibitor:  0.022
CYP2C19-substrate:  0.595
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.262
CYP2D6-inhibitor:  0.015
CYP2D6-substrate:  0.664
CYP3A4-inhibitor:  0.007
CYP3A4-substrate:  0.305

ADMET: Excretion

Clearance (CL):  12.017
Half-life (T1/2):  0.878

ADMET: Toxicity

hERG Blockers:  0.015
Human Hepatotoxicity (H-HT):  0.155
Drug-inuced Liver Injury (DILI):  0.228
AMES Toxicity:  0.024
Rat Oral Acute Toxicity:  0.065
Maximum Recommended Daily Dose:  0.031
Skin Sensitization:  0.818
Carcinogencity:  0.492
Eye Corrosion:  0.015
Eye Irritation:  0.572
Respiratory Toxicity:  0.07

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC63562

Natural Product ID:  NPC63562
Common Name*:   5-(Hydroxymethyl)-2,4-Dimethylpyridin-3-Ol
IUPAC Name:   5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol
Synonyms:  
Standard InCHIKey:  KKOWAYISKWGDBG-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C8H11NO2/c1-5-7(4-10)3-9-6(2)8(5)11/h3,10-11H,4H2,1-2H3
SMILES:  OCc1cnc(c(c1C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3244689
PubChem CID:   6094
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000089] Pyridines and derivatives
        • [CHEMONTID:0004152] Methylpyridines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. leaf n.a. DOI[10.1016/S0031-9422(01)00320-X]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. leaf n.a. PMID[11738417]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. fruit n.a. PMID[21462031]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO26293 Ginkgo biloba Species Ginkgoaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3577 Cell Line TA3 Mus musculus ID50 = 6.8 10'-8M PMID[502738]
NPT3578 Individual Protein Pyridoxine-5'-phosphate oxidase Mus musculus ID50 = 6.8 10'-8M PMID[502739]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC63562 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9862 High Similarity NPC269919
0.9862 High Similarity NPC132680
0.9728 High Similarity NPC324203
0.9728 High Similarity NPC63338
0.9728 High Similarity NPC322976
0.9597 High Similarity NPC263439
0.9467 High Similarity NPC211187
0.9221 High Similarity NPC256828
0.8938 High Similarity NPC52831
0.8938 High Similarity NPC325705
0.8503 High Similarity NPC36498
0.8421 Intermediate Similarity NPC220523
0.8089 Intermediate Similarity NPC153769
0.7977 Intermediate Similarity NPC3715
0.7892 Intermediate Similarity NPC252590
0.7834 Intermediate Similarity NPC161292
0.7831 Intermediate Similarity NPC473764
0.7831 Intermediate Similarity NPC314940
0.7821 Intermediate Similarity NPC471598
0.78 Intermediate Similarity NPC174421
0.7756 Intermediate Similarity NPC470403
0.7756 Intermediate Similarity NPC470404
0.7756 Intermediate Similarity NPC470394
0.7742 Intermediate Similarity NPC318935
0.7727 Intermediate Similarity NPC471596
0.7677 Intermediate Similarity NPC280853
0.7658 Intermediate Similarity NPC470395
0.7651 Intermediate Similarity NPC165370
0.7628 Intermediate Similarity NPC245657
0.7628 Intermediate Similarity NPC285016
0.759 Intermediate Similarity NPC473057
0.7545 Intermediate Similarity NPC471178
0.7533 Intermediate Similarity NPC212125
0.75 Intermediate Similarity NPC108469
0.75 Intermediate Similarity NPC471594
0.7442 Intermediate Similarity NPC194724
0.7423 Intermediate Similarity NPC284348
0.7414 Intermediate Similarity NPC478032
0.7396 Intermediate Similarity NPC477110
0.7372 Intermediate Similarity NPC29702
0.7372 Intermediate Similarity NPC328029
0.7371 Intermediate Similarity NPC219963
0.7365 Intermediate Similarity NPC25899
0.7353 Intermediate Similarity NPC44161
0.7349 Intermediate Similarity NPC116573
0.7349 Intermediate Similarity NPC138018
0.7337 Intermediate Similarity NPC476167
0.7321 Intermediate Similarity NPC471177
0.7321 Intermediate Similarity NPC59779
0.7321 Intermediate Similarity NPC124542
0.7305 Intermediate Similarity NPC84508
0.7303 Intermediate Similarity NPC306397
0.7288 Intermediate Similarity NPC207851
0.7285 Intermediate Similarity NPC151489
0.7283 Intermediate Similarity NPC192315
0.7278 Intermediate Similarity NPC97367
0.7267 Intermediate Similarity NPC253810
0.7263 Intermediate Similarity NPC46580
0.7249 Intermediate Similarity NPC316403
0.7247 Intermediate Similarity NPC314002
0.7239 Intermediate Similarity NPC257142
0.7228 Intermediate Similarity NPC224928
0.7226 Intermediate Similarity NPC256893
0.7225 Intermediate Similarity NPC5145
0.7219 Intermediate Similarity NPC48192
0.72 Intermediate Similarity NPC96890
0.7191 Intermediate Similarity NPC204717
0.7175 Intermediate Similarity NPC161887
0.7175 Intermediate Similarity NPC266551
0.716 Intermediate Similarity NPC471323
0.7158 Intermediate Similarity NPC226202
0.7151 Intermediate Similarity NPC295158
0.7143 Intermediate Similarity NPC203754
0.7143 Intermediate Similarity NPC150048
0.7135 Intermediate Similarity NPC220765
0.7128 Intermediate Similarity NPC470678
0.7128 Intermediate Similarity NPC8022
0.7128 Intermediate Similarity NPC470799
0.712 Intermediate Similarity NPC18348
0.712 Intermediate Similarity NPC477111
0.7111 Intermediate Similarity NPC171171
0.7102 Intermediate Similarity NPC184964
0.7095 Intermediate Similarity NPC284559
0.7093 Intermediate Similarity NPC41717
0.7081 Intermediate Similarity NPC251090
0.7076 Intermediate Similarity NPC102423
0.7069 Intermediate Similarity NPC158129
0.7069 Intermediate Similarity NPC273532
0.7065 Intermediate Similarity NPC329541
0.7062 Intermediate Similarity NPC42979
0.7056 Intermediate Similarity NPC314270
0.7056 Intermediate Similarity NPC241025
0.7056 Intermediate Similarity NPC42591
0.7053 Intermediate Similarity NPC470500
0.7052 Intermediate Similarity NPC319456
0.7045 Intermediate Similarity NPC224764
0.7043 Intermediate Similarity NPC267928
0.7037 Intermediate Similarity NPC60553
0.702 Intermediate Similarity NPC315804
0.702 Intermediate Similarity NPC313804
0.7018 Intermediate Similarity NPC79911
0.7017 Intermediate Similarity NPC314573
0.7016 Intermediate Similarity NPC477113
0.7 Intermediate Similarity NPC320394
0.6971 Remote Similarity NPC302647
0.6971 Remote Similarity NPC249614
0.697 Remote Similarity NPC173080
0.6963 Remote Similarity NPC329708
0.6963 Remote Similarity NPC118832
0.6963 Remote Similarity NPC165349
0.6963 Remote Similarity NPC264166
0.6963 Remote Similarity NPC274291
0.6963 Remote Similarity NPC472259
0.6963 Remote Similarity NPC47059
0.6961 Remote Similarity NPC62510
0.6959 Remote Similarity NPC120798
0.6957 Remote Similarity NPC114974
0.6944 Remote Similarity NPC48938
0.6943 Remote Similarity NPC315320
0.694 Remote Similarity NPC75544
0.694 Remote Similarity NPC32771
0.6932 Remote Similarity NPC313791
0.6923 Remote Similarity NPC263455
0.6919 Remote Similarity NPC133140
0.6919 Remote Similarity NPC195268
0.6919 Remote Similarity NPC177404
0.6919 Remote Similarity NPC71079
0.6919 Remote Similarity NPC99666
0.6914 Remote Similarity NPC126481
0.6911 Remote Similarity NPC475774
0.6911 Remote Similarity NPC200836
0.6901 Remote Similarity NPC113812
0.6901 Remote Similarity NPC230869
0.6898 Remote Similarity NPC242209
0.6882 Remote Similarity NPC289786
0.6879 Remote Similarity NPC469813
0.6879 Remote Similarity NPC78375
0.6879 Remote Similarity NPC474217
0.6879 Remote Similarity NPC476446
0.6868 Remote Similarity NPC20249
0.6863 Remote Similarity NPC244536
0.6862 Remote Similarity NPC156704
0.686 Remote Similarity NPC131718
0.6859 Remote Similarity NPC211813
0.6848 Remote Similarity NPC472289
0.6845 Remote Similarity NPC326634
0.6842 Remote Similarity NPC19872
0.6842 Remote Similarity NPC212742
0.6839 Remote Similarity NPC85918
0.6836 Remote Similarity NPC471294
0.6825 Remote Similarity NPC472284
0.6823 Remote Similarity NPC53144
0.6821 Remote Similarity NPC185782
0.6816 Remote Similarity NPC283152
0.6809 Remote Similarity NPC473053
0.6806 Remote Similarity NPC155792
0.6804 Remote Similarity NPC88008
0.6802 Remote Similarity NPC202605
0.6802 Remote Similarity NPC112206
0.6802 Remote Similarity NPC26679
0.68 Remote Similarity NPC127730
0.68 Remote Similarity NPC278366
0.6796 Remote Similarity NPC470474
0.6792 Remote Similarity NPC324611
0.6791 Remote Similarity NPC307963
0.6791 Remote Similarity NPC106937
0.6788 Remote Similarity NPC475070
0.678 Remote Similarity NPC121658
0.678 Remote Similarity NPC14651
0.6778 Remote Similarity NPC164340
0.6772 Remote Similarity NPC90229
0.6772 Remote Similarity NPC77555
0.6766 Remote Similarity NPC302159
0.676 Remote Similarity NPC134586
0.6757 Remote Similarity NPC44354
0.6757 Remote Similarity NPC110741
0.6757 Remote Similarity NPC230805
0.6754 Remote Similarity NPC315491
0.6754 Remote Similarity NPC45459
0.6754 Remote Similarity NPC249040
0.6754 Remote Similarity NPC213308
0.6752 Remote Similarity NPC471313
0.6752 Remote Similarity NPC471311
0.675 Remote Similarity NPC322488
0.6744 Remote Similarity NPC475870
0.6742 Remote Similarity NPC259545
0.674 Remote Similarity NPC317010
0.6738 Remote Similarity NPC324149
0.6736 Remote Similarity NPC476138
0.6736 Remote Similarity NPC245816
0.6724 Remote Similarity NPC315214
0.6724 Remote Similarity NPC47298
0.6723 Remote Similarity NPC476518
0.6722 Remote Similarity NPC211997
0.6721 Remote Similarity NPC62069
0.6707 Remote Similarity NPC167400
0.6705 Remote Similarity NPC98187
0.6704 Remote Similarity NPC95898
0.6702 Remote Similarity NPC476578
0.6702 Remote Similarity NPC4071

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC63562 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9862 High Similarity NPD9382 Approved
0.9862 High Similarity NPD9383 Approved
0.9728 High Similarity NPD9398 Clinical (unspecified phase)
0.8938 High Similarity NPD9510 Approved
0.8562 High Similarity NPD2123 Phase 3
0.8503 High Similarity NPD9364 Phase 2
0.8503 High Similarity NPD9363 Approved
0.8304 Intermediate Similarity NPD5317 Clinical (unspecified phase)
0.8204 Intermediate Similarity NPD9362 Approved
0.8114 Intermediate Similarity NPD1229 Phase 2
0.8089 Intermediate Similarity NPD9706 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD604 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD9690 Approved
0.7651 Intermediate Similarity NPD926 Approved
0.7651 Intermediate Similarity NPD925 Approved
0.7548 Intermediate Similarity NPD9506 Approved
0.7533 Intermediate Similarity NPD9284 Approved
0.7515 Intermediate Similarity NPD5255 Approved
0.75 Intermediate Similarity NPD5751 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD424 Approved
0.75 Intermediate Similarity NPD425 Approved
0.7485 Intermediate Similarity NPD861 Approved
0.7485 Intermediate Similarity NPD863 Approved
0.7485 Intermediate Similarity NPD862 Approved
0.7472 Intermediate Similarity NPD1213 Phase 3
0.747 Intermediate Similarity NPD112 Approved
0.747 Intermediate Similarity NPD9705 Discontinued
0.7384 Intermediate Similarity NPD158 Discontinued
0.7374 Intermediate Similarity NPD5316 Approved
0.7303 Intermediate Similarity NPD9080 Approved
0.7299 Intermediate Similarity NPD6159 Phase 2
0.7296 Intermediate Similarity NPD1649 Discontinued
0.7278 Intermediate Similarity NPD9076 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD203 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD1352 Discontinued
0.7253 Intermediate Similarity NPD9695 Approved
0.7246 Intermediate Similarity NPD2581 Approved
0.7246 Intermediate Similarity NPD2582 Approved
0.7207 Intermediate Similarity NPD5256 Discontinued
0.7167 Intermediate Similarity NPD1034 Phase 3
0.7167 Intermediate Similarity NPD1033 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1418 Phase 2
0.716 Intermediate Similarity NPD3813 Approved
0.7151 Intermediate Similarity NPD6872 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD2176 Approved
0.7151 Intermediate Similarity NPD2177 Approved
0.7151 Intermediate Similarity NPD2175 Phase 3
0.7151 Intermediate Similarity NPD2781 Approved
0.7135 Intermediate Similarity NPD2782 Approved
0.7135 Intermediate Similarity NPD2780 Approved
0.7135 Intermediate Similarity NPD1622 Discontinued
0.711 Intermediate Similarity NPD565 Phase 2
0.7104 Intermediate Similarity NPD6569 Phase 2
0.7104 Intermediate Similarity NPD9689 Approved
0.7099 Intermediate Similarity NPD3525 Discontinued
0.7072 Intermediate Similarity NPD2383 Phase 1
0.7045 Intermediate Similarity NPD5100 Phase 3
0.703 Intermediate Similarity NPD4703 Approved
0.703 Intermediate Similarity NPD4702 Approved
0.702 Intermediate Similarity NPD534 Phase 2
0.702 Intermediate Similarity NPD537 Phase 2
0.6995 Remote Similarity NPD8063 Discontinued
0.6979 Remote Similarity NPD796 Phase 2
0.6963 Remote Similarity NPD4038 Approved
0.6963 Remote Similarity NPD4122 Approved
0.6963 Remote Similarity NPD4035 Approved
0.6963 Remote Similarity NPD4039 Approved
0.6963 Remote Similarity NPD4037 Approved
0.6963 Remote Similarity NPD31 Approved
0.6963 Remote Similarity NPD32 Approved
0.6963 Remote Similarity NPD4033 Approved
0.6963 Remote Similarity NPD4034 Approved
0.6963 Remote Similarity NPD4036 Approved
0.6959 Remote Similarity NPD687 Clinical (unspecified phase)
0.6952 Remote Similarity NPD2952 Discontinued
0.6943 Remote Similarity NPD9206 Approved
0.6943 Remote Similarity NPD9207 Approved
0.6941 Remote Similarity NPD4670 Clinical (unspecified phase)
0.6941 Remote Similarity NPD4671 Clinical (unspecified phase)
0.6941 Remote Similarity NPD4669 Clinical (unspecified phase)
0.6919 Remote Similarity NPD3924 Approved
0.6919 Remote Similarity NPD3921 Approved
0.6919 Remote Similarity NPD3923 Approved
0.6919 Remote Similarity NPD3922 Approved
0.6906 Remote Similarity NPD1096 Discontinued
0.6902 Remote Similarity NPD3321 Discontinued
0.6898 Remote Similarity NPD3477 Phase 2
0.6898 Remote Similarity NPD3478 Clinical (unspecified phase)
0.689 Remote Similarity NPD3717 Discontinued
0.6889 Remote Similarity NPD7414 Clinical (unspecified phase)
0.6889 Remote Similarity NPD1783 Clinical (unspecified phase)
0.6889 Remote Similarity NPD4203 Approved
0.6889 Remote Similarity NPD4204 Approved
0.6878 Remote Similarity NPD9687 Approved
0.6878 Remote Similarity NPD9688 Approved
0.6875 Remote Similarity NPD485 Clinical (unspecified phase)
0.6875 Remote Similarity NPD1078 Clinical (unspecified phase)
0.6872 Remote Similarity NPD1620 Clinical (unspecified phase)
0.6868 Remote Similarity NPD3082 Discontinued
0.6865 Remote Similarity NPD4699 Discontinued
0.6863 Remote Similarity NPD4086 Phase 1
0.6848 Remote Similarity NPD8823 Approved
0.6848 Remote Similarity NPD4021 Phase 2
0.6845 Remote Similarity NPD3395 Approved
0.6845 Remote Similarity NPD3396 Approved
0.6842 Remote Similarity NPD4396 Clinical (unspecified phase)
0.6837 Remote Similarity NPD4131 Phase 3
0.6837 Remote Similarity NPD3779 Clinical (unspecified phase)
0.6805 Remote Similarity NPD9595 Approved
0.6805 Remote Similarity NPD9596 Approved
0.6804 Remote Similarity NPD6290 Phase 2
0.6804 Remote Similarity NPD1392 Approved
0.6791 Remote Similarity NPD4551 Phase 2
0.6791 Remote Similarity NPD5575 Clinical (unspecified phase)
0.6791 Remote Similarity NPD1038 Approved
0.6791 Remote Similarity NPD802 Phase 2
0.6776 Remote Similarity NPD6344 Clinical (unspecified phase)
0.6772 Remote Similarity NPD7948 Phase 1
0.6761 Remote Similarity NPD5862 Discovery
0.6757 Remote Similarity NPD9714 Clinical (unspecified phase)
0.6754 Remote Similarity NPD484 Approved
0.6751 Remote Similarity NPD5936 Approved
0.6751 Remote Similarity NPD3570 Phase 2
0.6751 Remote Similarity NPD4502 Phase 2
0.6751 Remote Similarity NPD5939 Approved
0.6744 Remote Similarity NPD9574 Clinical (unspecified phase)
0.6742 Remote Similarity NPD2077 Approved
0.6742 Remote Similarity NPD2076 Approved
0.6739 Remote Similarity NPD3039 Clinical (unspecified phase)
0.6724 Remote Similarity NPD1685 Approved
0.6724 Remote Similarity NPD1684 Approved
0.6722 Remote Similarity NPD1032 Phase 2
0.6721 Remote Similarity NPD5083 Clinical (unspecified phase)
0.6709 Remote Similarity NPD5352 Clinical (unspecified phase)
0.6707 Remote Similarity NPD9075 Approved
0.6707 Remote Similarity NPD9074 Approved
0.6705 Remote Similarity NPD704 Clinical (unspecified phase)
0.6686 Remote Similarity NPD1274 Clinical (unspecified phase)
0.6685 Remote Similarity NPD4889 Approved
0.6683 Remote Similarity NPD2616 Phase 3
0.6683 Remote Similarity NPD2615 Phase 3
0.6667 Remote Similarity NPD6389 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8356 Approved
0.6667 Remote Similarity NPD3932 Clinical (unspecified phase)
0.6651 Remote Similarity NPD2414 Clinical (unspecified phase)
0.6649 Remote Similarity NPD4375 Approved
0.6649 Remote Similarity NPD4372 Phase 1
0.6649 Remote Similarity NPD7889 Clinical (unspecified phase)
0.6633 Remote Similarity NPD3930 Clinical (unspecified phase)
0.6633 Remote Similarity NPD7222 Phase 2
0.6631 Remote Similarity NPD2544 Clinical (unspecified phase)
0.663 Remote Similarity NPD4071 Approved
0.663 Remote Similarity NPD4072 Approved
0.6618 Remote Similarity NPD6553 Clinical (unspecified phase)
0.6615 Remote Similarity NPD5999 Phase 2
0.6614 Remote Similarity NPD4529 Approved
0.6614 Remote Similarity NPD4526 Approved
0.6614 Remote Similarity NPD4528 Approved
0.6612 Remote Similarity NPD1570 Approved
0.6612 Remote Similarity NPD3386 Phase 2
0.6611 Remote Similarity NPD1923 Clinical (unspecified phase)
0.6601 Remote Similarity NPD7203 Clinical (unspecified phase)
0.6598 Remote Similarity NPD3931 Approved
0.6598 Remote Similarity NPD3928 Approved
0.6596 Remote Similarity NPD4148 Approved
0.6593 Remote Similarity NPD1503 Clinical (unspecified phase)
0.6588 Remote Similarity NPD3576 Approved
0.6588 Remote Similarity NPD3575 Approved
0.6585 Remote Similarity NPD4945 Discontinued
0.658 Remote Similarity NPD1739 Approved
0.658 Remote Similarity NPD1740 Approved
0.6576 Remote Similarity NPD5596 Phase 2
0.6571 Remote Similarity NPD2511 Approved
0.657 Remote Similarity NPD7603 Discontinued
0.657 Remote Similarity NPD5640 Discontinued
0.6566 Remote Similarity NPD4437 Phase 3
0.6559 Remote Similarity NPD706 Phase 1
0.6557 Remote Similarity NPD2600 Approved
0.6557 Remote Similarity NPD2599 Approved
0.6557 Remote Similarity NPD2601 Approved
0.6552 Remote Similarity NPD8109 Clinical (unspecified phase)
0.655 Remote Similarity NPD3330 Phase 1
0.6548 Remote Similarity NPD751 Clinical (unspecified phase)
0.6545 Remote Similarity NPD1380 Discovery
0.6543 Remote Similarity NPD4081 Clinical (unspecified phase)
0.6538 Remote Similarity NPD8430 Approved
0.6537 Remote Similarity NPD7726 Phase 1
0.6536 Remote Similarity NPD7474 Suspended
0.6536 Remote Similarity NPD4724 Clinical (unspecified phase)
0.6535 Remote Similarity NPD5612 Discontinued
0.6531 Remote Similarity NPD4795 Phase 2
0.6526 Remote Similarity NPD1304 Clinical (unspecified phase)
0.6526 Remote Similarity NPD6361 Phase 2
0.6524 Remote Similarity NPD8020 Approved
0.6524 Remote Similarity NPD8021 Approved
0.6519 Remote Similarity NPD5065 Approved
0.6512 Remote Similarity NPD2882 Phase 1
0.6512 Remote Similarity NPD6476 Clinical (unspecified phase)
0.6512 Remote Similarity NPD6158 Phase 2
0.6508 Remote Similarity NPD2334 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data